COURSERA INC (COUR) Fundamental Analysis & Valuation

NYSE:COUR • US22266M1045

Current stock price

5.36 USD
-0.24 (-4.29%)
At close:
5.41 USD
+0.05 (+0.93%)
After Hours:

This COUR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. COUR Profitability Analysis

1.1 Basic Checks

  • COUR had positive earnings in the past year.
  • COUR had a positive operating cash flow in the past year.
  • In the past 5 years COUR always reported negative net income.
  • Of the past 5 years COUR 4 years had a positive operating cash flow.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • COUR has a worse Return On Assets (-5.10%) than 63.01% of its industry peers.
  • The Return On Equity of COUR (-8.02%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

  • The Gross Margin of COUR (54.57%) is better than 65.75% of its industry peers.
  • In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
  • COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. COUR Health Analysis

2.1 Basic Checks

  • COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • COUR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, COUR has more shares outstanding
  • COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • COUR has an Altman-Z score of 1.43. This is a bad value and indicates that COUR is not financially healthy and even has some risk of bankruptcy.
  • COUR has a Altman-Z score (1.43) which is in line with its industry peers.
  • COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.43
ROIC/WACCN/A
WACC8.95%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that COUR has no problem at all paying its short term obligations.
  • COUR's Current ratio of 2.51 is amongst the best of the industry. COUR outperforms 84.93% of its industry peers.
  • A Quick Ratio of 2.51 indicates that COUR has no problem at all paying its short term obligations.
  • The Quick ratio of COUR (2.51) is better than 86.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. COUR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.65% over the past year.
  • Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 9.04% in the last year.
  • The Revenue has been growing by 20.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%

3.2 Future

  • Based on estimates for the next years, COUR will show a very strong growth in Earnings Per Share. The EPS will grow by 20.72% on average per year.
  • The Revenue is expected to grow by 5.50% on average over the next years.
EPS Next Y9.85%
EPS Next 2Y15.55%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue Next Year8.02%
Revenue Next 2Y7.21%
Revenue Next 3Y5.5%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. COUR Valuation Analysis

4.1 Price/Earnings Ratio

  • COUR is valuated correctly with a Price/Earnings ratio of 13.40.
  • COUR's Price/Earnings ratio is a bit cheaper when compared to the industry. COUR is cheaper than 72.60% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.78. COUR is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 12.20, COUR is valued correctly.
  • COUR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. COUR is cheaper than 78.08% of the companies in the same industry.
  • COUR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.4
Fwd PE 12.2
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, COUR is valued cheaper than 80.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • COUR's earnings are expected to grow with 20.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y15.55%
EPS Next 3Y20.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COUR Dividend Analysis

5.1 Amount

  • No dividends for COUR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COUR Fundamentals: All Metrics, Ratios and Statistics

COURSERA INC

NYSE:COUR (4/10/2026, 8:14:45 PM)

After market: 5.41 +0.05 (+0.93%)

5.36

-0.24 (-4.29%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners92.57%
Inst Owner Change0%
Ins Owners4.94%
Ins Owner Change1.08%
Market Cap907.50M
Revenue(TTM)757.50M
Net Income(TTM)-51.00M
Analysts76.47
Price Target10.1 (88.43%)
Short Float %17.01%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.68%
Min EPS beat(2)-1.96%
Max EPS beat(2)17.31%
EPS beat(4)3
Avg EPS beat(4)25.3%
Min EPS beat(4)-1.96%
Max EPS beat(4)49.74%
EPS beat(8)7
Avg EPS beat(8)297.92%
EPS beat(12)11
Avg EPS beat(12)902.16%
EPS beat(16)14
Avg EPS beat(16)684.85%
Revenue beat(2)2
Avg Revenue beat(2)0.33%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.63%
Revenue beat(4)4
Avg Revenue beat(4)0.62%
Min Revenue beat(4)0.03%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.01%
Revenue beat(12)9
Avg Revenue beat(12)0.91%
Revenue beat(16)12
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)-15.58%
EPS NQ rev (1m)1.46%
EPS NQ rev (3m)-26.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.97%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE 13.4
Fwd PE 12.2
P/S 1.2
P/FCF 11.56
P/OCF 8.35
P/B 1.43
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.4
EY7.46%
EPS(NY)0.44
Fwd EY8.2%
FCF(TTM)0.46
FCFY8.65%
OCF(TTM)0.64
OCFY11.98%
SpS4.47
BVpS3.75
TBVpS3.59
PEG (NY)1.36
PEG (5Y)N/A
Graham Number5.81
Profitability
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.57%
FCFM 10.36%
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 104.86%
Cap/Sales 3.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z 1.43
F-Score6
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)115.48%
Cap/Depr(5y)105.87%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y9.85%
EPS Next 2Y15.55%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%
Revenue Next Year8.02%
Revenue Next 2Y7.21%
Revenue Next 3Y5.5%
Revenue Next 5YN/A
EBIT growth 1Y24.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year174.69%
EBIT Next 3Y69.52%
EBIT Next 5YN/A
FCF growth 1Y32.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.99%
OCF growth 3YN/A
OCF growth 5YN/A

COURSERA INC / COUR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to COUR.


What is the valuation status of COURSERA INC (COUR) stock?

ChartMill assigns a valuation rating of 5 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


Can you provide the profitability details for COURSERA INC?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for COUR stock?

The Price/Earnings (PE) ratio for COURSERA INC (COUR) is 13.4 and the Price/Book (PB) ratio is 1.43.


How financially healthy is COURSERA INC?

The financial health rating of COURSERA INC (COUR) is 7 / 10.